REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 166 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $635 | -16.2% | 19,719 | -52.0% | 0.01% | -33.3% |
| Q4 2022 | $758 | -99.9% | 41,076 | -44.6% | 0.02% | -44.4% |
| Q2 2022 | $1,024,000 | -41.4% | 74,119 | -17.3% | 0.03% | -34.1% |
| Q1 2022 | $1,747,000 | -8.8% | 89,572 | +38.6% | 0.04% | +13.9% |
| Q2 2021 | $1,915,000 | +417.6% | 64,616 | +137.6% | 0.04% | +350.0% |
| Q2 2016 | $370,000 | -1.6% | 27,200 | +147.3% | 0.01% | -27.3% |
| Q4 2015 | $376,000 | – | 11,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |